Close Menu

NEW YORK – Enzo Biochem reported after the close of the market on Tuesday that its fourth quarter revenues fell nearly 7 percent year over year, due to a 26 percent decrease in revenues from its life sciences business unit.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.